Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets

Documenti analoghi

• A20-binding Inhibitor of Nuclear Factor-κB (NF-κB)-2 (ABIN-2) Is an Activator of Inhibitor of NF-κB (IκB) Kinase α (IKKα)-mediated NF-κB Transcriptional Activity
  di: Leotoing, Laurent, et al.
  Pubblicazione: (2011)
• NF-κB-inducing kinase (NIK) prevents the development of hypereosinophilic syndrome (HES)-like disease in mice independent of IKKα activation
  di: Häcker, Hans, et al.
  Pubblicazione: (2012)
• Control of canonical NF-κB activation through the NIK–IKK complex pathway
  di: Zarnegar, Brian, et al.
  Pubblicazione: (2008)
• Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation
  di: Razani, Bahram, et al.
  Pubblicazione: (2010)
• NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176
  di: Ling, Lei, et al.
  Pubblicazione: (1998)